Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1988-01-06
1991-05-21
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 854, 424 857, A61K 3766
Patent
active
050173715
ABSTRACT:
Low doses of interferon contacted with the oral and pharyngeal mucosa of a patient in conjunction with administration of radiation therapy or chemotherapy reduces the toxic side effects associated with administration of said cancer therapy.
REFERENCES:
patent: 3536809 (1980-10-01), Applezweig
patent: 3906092 (1975-09-01), Hilleman et al.
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4053582 (1977-10-01), Stickl
patent: 4226848 (1980-10-01), Nagai et al.
patent: 4273703 (1981-06-01), Osther et al.
patent: 4276282 (1981-06-01), Sugimoto et al.
patent: 4460574 (1984-07-01), Yabrov
patent: 4462985 (1984-07-01), Cummins, Jr.
patent: 4497795 (1985-05-01), Cummins
patent: 4572832 (1986-02-01), Kigasawa et al.
patent: 4605555 (1988-04-01), Sato et al.
patent: 4649075 (1987-03-01), Jost
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4746508 (1988-05-01), Carey et al.
patent: 4764378 (1988-08-01), Keith et al.
Goldstein, D. et al., Cancer Research, vol. 46, pp. 4315-4329, 1986.
"Alpha Interferon: A Look to the Future", Eric M. Bonnem, Investigational New Drugs 5, Suppl. 65-75 (1987), Nijhoff Publishers, Boston, pp. S65-S-75.
Rodder, H., Thumann, D., Thumann, E., Tierarztliche Umschau, vol. 34, No. 10, 1979, pp. 720-724 (summary).
Toneva, V., Bulletin de l'Office International des Epizooties, vol. 88, 1977, pp. 631-637 (Summary).
"In Vivo and Clinical Studies", Norman B. Finter & Robert K. Oldham, eds., Interferon, vol. 4, 1985, pp. 137, 148, 173, 218, 226, 284, 285, 330.
Chemical Abstracts, vol. 67, 1967, p. 7536 [80070u], Litvinov, A. N.
"Time and Dosage Dependence of Immunoenhancement by Murine Type II Interferon Preparations", Cellular Immunology, 40, 1978, pp. 285-293.
"Interferons and Their Actions", W. E. Stewart II and A. A. Gottlieb, eds., 1977, pp. 102-104.
"Antiviral Effect of Bacterially Produced Human Interferon (Hu-IFNA.sub.2) Against Experimental Vaccinia Infection in Calves", Journal of Interferon Research, 5:129-136, 1985, Werenne, J., Broecke, C. V., Schwers, A., Goossens, A., Bugyaki, L., et al.
"Effect of Human Leukocyte A Interferon on Prevention of Infectious Bovine Rhinotracheitis Virus Infection of Cattle", Roney, C. S. et al., Am. J. Vet. Res., vol. 46, No. 6, Jun. 1985, pp. 1251-1255.
"Response of Feline Leukemia Virus-Induced Nonregenerative Anemia to Oral Administration of an Interferon-Containing Preparation", Feline Practice, vol. 12, No. 3, May-Jun. 1982, pp. 6-15, Tompkins, M. B. and Cummins, J. M.
"Interferon Enters the Fray", Farm Journal, Oct. 1985, pp. 12-13, Miller, B.
"Interferon as an Adjuvant for Hepatitis B Vaccinationin Non- and Low-Responder Populations", Grob, P. J. et al., Eur. J. Clin. Microbiol., Jun. 1984, vol. 3, No. 3, pp. 195-198.
"Protection of Calves Against Rhinovirus Infection by Nasal Secretion Interferon Induced by Infectious Bovine Rhinotracheitis Virus", American Journal of Veterinary Research, Cummins, J. M. and Rosenquist, B. D., Feb. 1980, vol. 41, No. 2, pp. 161-165.
"Bovine Respiratory Disease--A Symposium", R. W. Loan, ed., Texas A&M University Press, College Station, Tex. 1984, pp. 484-485.
"Activity of Exogenous Interferon in the Human Nasal Mucosa", Texas Reports on Biology and Medicine, vol. 35, 1977, Greenberg, S. B., Harmon, M. W. and Johnson, P. E., pp. 491-496.
"Inhibition of Respiratory Virus Infection by Locally Applied Interferon", Merigan, T. C., Hall, T. S., Reed, S. E., and Tyrrell, D. A., The Lancet, Mar. 17, 1973, pp. 563-567.
"Trials of Interferon in Respiratory Infections of Man", Tyrrell, D. A. J., Texas Reports on Biology and Medicine, vol. 35, 1977, pp. 486-490.
"Bacteria-Derived Human Leukocyte Interferons After in Vitro Humoral and Cellular Immune Responses", Cellular Immunology, 82, 1983, pp. 269-281, by Shalaby, M. R. and Weck, P. K.
"Clinical and Laboratory Investigations on Man: Systemic Administration of Potent Interferon to Man", J. Natl. Cancer Inst., 51: 733-742, 1973, by Strander, H., Cantell, K., Carlstrom, G. and Jakobsson, P. A.
"Application of Human Leukocyte Interferon in Severe Cases of Virus B Hepatitis", Vlatkovic, R., et al., Proc. Symposium on Interferon 1979, Yugoslav Academy of Sciences and Arts, Zagreb, pp. 173-183.
"Effect of Interferon on Vaccination in Volunteers", The Lancet, Apr. 28, 1962, pp. 873-875 (Report to Medical Research Council from the Scientific Committee on Interfron).
"Induction of Ocular Resistance to Vaccinia Virus by Typhoid Vaccine: Role of Interferon", Oh, J. O., and Yoneda, C., The Journal of Immunology, vol. 102, No. 1, 1969, pp. 145-154.
"Clinical Trials with Exogenous Interferon: Summary of a Meeting", The Journal of Infections Diseases, vol. 139, No. 1, Jan. 1979, pp. 109-123.
"Some Results and Prospects in the Study of Endogenous and Exogenous Interferon", The Interferson, An International Symposium, Soloviev, V. D., Geo. Rita, ed., Academic Press, 1968, pp. 233-243.
"Influenza and Interferon Research in the Soviet Union--Jan. 1973", The Journal of Infectitous Diseases, vol. 128, No. 2, Aug. 1973, pp. 261-264.
"The Results of Controlled Observations on the Prophylaxis of Influenza with Interferon", Solov'ev, V. D., World Health Organization, 1949, 41, 683-688.
"Children's Respiratory Viral Diseases Treated with Interferon Aerosol", Jia-xiong, D. et al., Chinese Medical Journal, 100(2): 162-166, 1987.
Essential Clinical Virology, R. G. Sommerville, Blackwell Scientific Publications, pp. 154-157.
"Comparative Intranasal Pharmacokinetics of Interferon Using Two Spray Systems", Davies, H. W. et al., J. Interferon Research, 1983, pp. 443-449.
"The Common Cold Control?", Couch, R. B., The Journal of Infectitious Diseases, vol. 150, No. 2, Aug. 1984, pp. 167-173.
Principles and Practice of Infectious Diseases, 2nd. ed., Mandell, G. L., Douglas, R. G. Jr., Bennett, J. E. eds., A Wiley Medical publication, pp. 85-96, 863, 968.
Antiviral Agents and Viral Diseases of Man, edited by G. J. Galasso, T. C. Merigan, R. A. Buchanan, Raven Press, New York, 1979, pp. 407-408, 430-431.
Antiviral Agents and Viral Diseases of Man,edited by G. J. Galasso, T. C. Merigan, R. A. Buchanan, Raven Press, New York, 1984, pp. 145-178, 344-345.
"Interferon Perspective", Information on Interferon provided in 1981 by the International Preventative Medicine Foundation, Melbourne, Fla., Ronald Jones, Vice President.
American Interhealth, Melbourne Beach, Florida, production information.
Biovet International, Inc., Canine and Feline Interferons, 1981 product description and label.
"Agriferon.RTM.-C", Immuno Modulators Laboratories, Inc., Stafford, Texas, Lymphokine Preparation for Prophylactic Treatment of Infectious Bovine Rhinotracheitis Virus Associated with Shipping Fever--for cattle use in Texas only, product brochure.
"Agriferon.RTM.-C", A Bold New Approach to Managing Shipping Fever in Cattle, Immuno Modulators Laboratories, Inc., Stafford, Texas, product advertisement.
"Equiferon" A Totally New Approach to Viral Respiratory Infection in Horses, Immuno Modulator Laboratories, Inc., Stafford, Texas, 1985, product advertisement.
"Pet Interferon Alpha", Amarillo Cell Culture Company, Inc., Amarillo, Texas, Lymphokine Preparation for Treatment of Feline Leukemia Virus and Canine Parvovirus Diseases, product brochure.
Texas Department of Health application for license, Amarillo Cell Culture Company, Inc., for human interferon alpha, (Alpha Interferon) as Pet Interferon, May 6, 1985.
"Circulating Interferon in Rabbits After Administration of Human Interferon by Different Routes", Cantel, K. and Ryhala, L., Journal of General Virology, (1973), 20, pp. 97-104.
"Pharmacokinetics of Recombinant Alpha A Interferon Following IV Infusion and Bolus, IM, and PO Administrations to African Green Monkeys", Wills, R. J., Spiegel, H. E., and Soikel, K. F., Journal of Interferon Research, vol. 4, No. 3, 1984, pp. 399-409.
"Pharmacokinetics of Recombinant Leukocyte A Interferon Following Various Routes and Modes of Administration to the Dog", Gibson, D. M. et al., Journal of Interferon Research, 5:403-408 (1985).
"Stimulation of Humoral Immunity by Interferon", III Mediterranean Congress of
Amarillo Cell Culture Company, Incorporated
Koh Choon P.
Schain Howard E.
LandOfFree
Method for reducing side effects of cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing side effects of cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing side effects of cancer therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-236787